Stallergenes Greer Revenue and Competitors

London, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Stallergenes Greer's estimated annual revenue is currently $249.4M per year.(i)
  • Stallergenes Greer's estimated revenue per employee is $201,000

Employee Data

  • Stallergenes Greer has 1241 Employees.(i)
  • Stallergenes Greer grew their employee count by 2% last year.

Stallergenes Greer's People

NameTitleEmail/Phone
1
CIO - Stallergenes (Pharma)Reveal Email/Phone
2
CFOReveal Email/Phone
3
Head Business DevelopmentReveal Email/Phone
4
VP, Human SCIT & Animal HealthReveal Email/Phone
5
VP, Head Food AllergyReveal Email/Phone
6
VP, Global Strategic SourcingReveal Email/Phone
7
Head Communications & CSR, member Stallergenes Greer’s Global leadership teamReveal Email/Phone
8
Head Pricing Market Access and Public AffairsReveal Email/Phone
9
Head Immunochemistry- Research and Pharmaceutical DevelopmentReveal Email/Phone
10
Head Sales GermanyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Stallergenes Greer?

Stallergenes Greer is a global biopharmaceutical company specialising in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. \n\nOur purpose is to enable precision medicine to improve life for people with allergies. \n\nWith more than 1,100 employees worldwide, a presence in 40 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer Ltd is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France). \n\nWith complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.

keywords:N/A

N/A

Total Funding

1241

Number of Employees

$249.4M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Stallergenes Greer News

2022-04-20 - Sublingual Allergy Immunotherapy Market Outlook 2022-2030 ...

Stallergenes Greer; Merck; Allergy Therapeutics; Hal-Allergy; ALK-Abello. Global market segmentation Sublingual Allergy Immunotherapy : Sublingual Allergy...

2022-04-19 - Worldwide Allergy Immunotherapy Industry to 2028 ...

... Key companies covered as a part of this study include Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma,...

2022-04-17 - Allergy Immunotherapies Market Size, Outlook And Forecast ...

ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, WOLW Pharma, Holister Stier, Leti.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$313.5M12446%N/A
#2
$427M1245-12%N/A
#3
$408.2M124648%N/A
#4
$75M12519%N/A
#5
$35M12575%N/A